• Featured Product
  • KD/KO Validated

KMT2D Polyklonaler Antikörper

KMT2D Polyklonal Antikörper für IHC, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IHC, IF, ChIP, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 27266-1-AP

Synonyme

AAD10, ALL1 related protein, ALR, CAGL114, KMT2D, Lysine N methyltransferase 2B, MLL2, MLL4, TNRC21



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHEK-293-Zellen
Erfolgreiche Detektion in IHChumanes Mammakarzinomgewebe, humanes Kolonkarzinomgewebe, humanes Lymphomgewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:2000-1:16000
Immunhistochemie (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

27266-1-AP bindet in WB, IHC, IF, ChIP, ELISA KMT2D und zeigt Reaktivität mit human

Getestete Reaktivität human
In Publikationen genannte Reaktivitäthuman
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen KMT2D fusion protein Ag26195
Vollständiger Name myeloid/lymphoid or mixed-lineage leukemia 2
Berechnetes Molekulargewicht 593 kDa
Beobachtetes Molekulargewicht593 kDa
GenBank-ZugangsnummerNM_003482
Gene symbol MLL2
Gene ID (NCBI) 8085
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

KMT2D (a COMPASS/ Set1 family member; also known as MLL4, ALR, and MLL2) is the biggest H3K4 methyltransferase among the most frequently mutated genes in many different types of cancer (PMID: 34194626). The enzymatic function of KMT2D depends on a cluster of C-terminal conserved domains, including a PHD domain, two FY-rich motifs (FYRC and FYRN) and a catalytic SET domain. KMT2D has two frequently occurring genomic alterations: truncation and missense mutations. Loss of KMT2D is a bona fide tumor suppressor gene in FL and DLBCL. Kmt2d perturbed the expression of genes that sustain proliferation and survival, and the KMT2D protein directly binds and associates with an active chromatin conformation in negative modulators of the BCR and lymphocyte migration pathways, which in turn could affect B cell responses to antigen(PMID: 26366712).

Protokolle

Produktspezifische Protokolle
WB protocol for KMT2D antibody 27266-1-APProtokoll herunterladen
IHC protocol for KMT2D antibody 27266-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Cancer Immunol Res

Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multiomics Analysis.

Authors - Xuanwen Bao
humanIHC

Oncogene

Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3.

Authors - Xuejiao Leng
humanIHC,IF

Cell Biosci

Histone methyltransferase KMT2D cooperates with MEF2A to promote the stem-like properties of oral squamous cell carcinoma.

Authors - Xinmiao Wang
humanIHC

Thorac Cancer

RNF213 gene mutation in circulating tumor DNA detected by targeted next-generation sequencing in the assisted discrimination of early-stage lung cancer from pulmonary nodules.

Authors - Ning Jiang
ChIP

Cell Death Discov

Pseudogene ACTBP2 increases blood-brain barrier permeability by promoting KHDRBS2 transcription through recruitment of KMT2D/WDR5 in Aβ1-42 microenvironment.

Authors - Qianshuo Liu
humanWB,IHC,IF

World J Gastrointest Oncol

KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma.

Authors - Si-Si Li
  • KD Validated